Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. The expression levels of MicroRNA-26a and -24 turned out to be promising predictors of further clinical course in patients with [[glioblastoma]] ((Sippl C, Teping F, Ketter R, Braun L, Tremmel L, Schulz-Schaeffer W, Oertel J, Urbschat S. The influence of distinct regulatory MicroRNAs of the p15/p16/RB1/E2F pathway on the clinical progression of glioblastoma. World Neurosurg. 2019 Jul 24. pii: S1878-8750(19)32040-6. doi: 10.1016/j.wneu.2019.07.134. [Epub ahead of print] PubMed PMID: 31351207. )). mir_24.txt Last modified: 2024/06/07 02:49by 127.0.0.1